iBio
IBIO
30 hedge funds and large institutions have $2.44M invested in iBio in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 10 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
6.43% less ownership
Funds ownership: 26.19% → 19.75% (-6.4%)
12% less funds holding
Funds holding: 34 → 30 (-4)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
76% less capital invested
Capital invested by funds: $10.4M → $2.44M (-$7.96M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$734K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$59.5K |
| 3 |
VF
Virtu Financial
New York
|
+$43.6K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$31K |
| 5 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$234K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$224K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$130K |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$116K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$97.1K |
IBIO Hedge Fund Activity: Q2 2025 in Review
30 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2025, worth a combined $2.44M — down 76% from $10.4M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of IBIO and 7 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 7 added.
The largest buyer was Lynx1 Capital Management, adding an estimated $734K. The largest seller was Iridian Asset Management, exiting entirely with an estimated $234K sold.
- 30 institutional investors held iBio (IBIO) as of Q2 2025, down from 34 in Q1 2025.
- Funds reported $2.44M of iBio stock for Q2 2025, down 76% quarter-over-quarter.
- 7 funds opened new iBio positions in Q2 2025 and 10 closed out, a net change of -3 holders.
- The largest iBio buyer in Q2 2025 was Lynx1 Capital Management, an estimated $734K added.
- The largest iBio seller in Q2 2025 was Iridian Asset Management, an estimated $234K sold.
Based on aggregated 13F filings for Q2 2025.